The global structural heart imaging market size was valued at USD 14.88 billion in 2020 and is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the wide prevalence of heart-related diseases such as congenital heart diseases (CHDs) and increasing government funding to improve the treatment facilities.
Structural heart imaging includes a range of techniques that are primarily designed to detect heart disease or disorders of a patient. Structural heart disease (SHD), as a disorder related to tissues of the heart, can be found among newly born babies or developed to the aging population due to increasing occurrence of infection and injury.
Request Free Sample Report Here
Patients suffering from SHD are likely to face some of the key consequence such as high blood pressure, arthrosclerosis, and heart attacks due to weakening of chambers and valves of the heart. CHDs are types of heart diseases that are present at birth and account for about a third of all major congenital defects worldwide.
Fusion of various imaging modalities is increasingly becoming more common for SHD diagnostic procedures because it allows high-quality images and real-time monitoring in the operating room. During the treatment of SHDs, real-time images are generated by combining echocardiography and fluoroscopy. Since magnetic resonance imaging (MRI) does not use ionizing radiation, it is a popular option for children and pregnant women for the disease diagnosis. MRI has also been useful for controlling myocardial and valve functions as well as diagnosing complex CHDs, thanks to technological advances.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing incidence of CHDs cases and increasing number of the aging population globally are key factors driving the market growth.
- Rising government support and initiatives to improve accessibility to advanced treatments of heart patients especially in developing regions are expected to fuel the market growth during the forecast period.
- Growing number of infants born with heart defects and several complications of heart congestion of newly born babies are key drivers of the market.
- Rapid development of new technology such as MR spectroscopy, perfusion, functional MRI, and diffusion tensor imaging, which are offering effective and accurate result of MRI. This is a major factor expected to boost the market.
Market Segment Insights
Angiogram segment is projected to constitute a large key market share
Based on imaging modality, the structural heart imaging market is bifurcated into echocardiogram and angiogram. The angiogram segment is further divided into MRI and CT. The angiogram segment is expected to constitute a key share of the market during the forecast period owing to wide adoption of MRI and CT scan for heart-related diagnosis and treatment. The growing need for accurate diagnosis and imaging for the detection of SHDs, especially CHDs, is likely to drive up demand for MRI and CT scan, which is projected to boost the overall market share of the segment.
Asia Pacific is anticipated to dominate the market
On the basis of regions, the structural heart imaging market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific is anticipated to expand at an impressive CAGR and the region is anticipated to dominate the market during the forecast period. Increasing awareness of cardiac diseases as a result of extensive initiatives coordinated by healthcare organizations such the World Health Organization (WHO) and various governments in the region. Moreover, implementation of newborn screening programs and increasing access to advanced healthcare facilities for heart patients are expected to boost the regional market growth.
Compititive Landscape
Key players competing in the structural heart imaging market are CardioComm Solutions Inc.; Circle Cardiovascular Imaging, Inc.; HeartSciences; Koninklijke Philips N.V.; Pie Medical Imaging; Shimadzu Corporation; Siemens Healthineers; TomTec Imaging Systems GmbH; and Toshiba Corporation. Some of these major players have adopted distribution and commercialization deals with well-established players, as well as the creation of creative technology to stay ahead in the competitive and enhance their market share in the market. For instance, at RSNA 2015, GE Healthcare demonstrated a groundbreaking MRI technique that offered a performance of a complete 3D chest volume scan.
About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com
From the last 10 years, tremendous growth have been noticed in Structural heart devices market.
With increasing population, and growing health awareness among people, the Structural Heart Disease Market is expected to expand at a very high rate.The structural heart devices market are categorized into the following segments and subsegments: o the basis of product: Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems, Annuloplasty Rings, Other Devices, Accessories; on the basis of procedure: Replacement Procedures, TAVR Procedures, SAVR Procedures, Repair Procedures, Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures; on the basis of geography: North America, Europe, Asia Pacific, Rest of the World.
Due to pollution and bad living habits, the cardiovascular diseases including structural heart diseases have become leading cause of death, now a days.
These factors are the key growth drivers of the Structure Heart Devices Market and will keep taking the market to new heights.The major restraints include the lack of availability of skilled cardiovascular Interventionist.
Whereas the increasing health awareness is helping in the growth of market and also the hospitals are these days following the international standards for these cardiovascular diseases.Among all the segments, Occluders and Delivery Systems are having the largest market share.
With the growing population, pollution is also increasing which in turn caused the scarcity of purified drinking water and adulteration of food.
Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others.
As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6385The structural heart devices market is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes.
In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed.
Several clinical trials and technology developments are underway, which is likely to provide the structural heart devices market opportunities for growth in the coming years.SegmentationThe structural heart devices market has been segmented based on type, indication, procedure, and end-user.By type, the structural heart devices market has been segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, accessories, and other devices.
The repair procedures segment has been further segmented into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures.By end-user, the structural heart devices market has been segmented into hospitals, ambulatory surgery centers, and others.Regional AnalysisRegion-wise, the structural heart devices market has been segmented into North America, Europe, the Middle East & Africa (MEA), and Asia Pacific (APAC).North America is the dominant market for structural heart devices.
High prevalence of cardiovascular disorders, fast uptake of the latest technologies, and high healthcare expenditure are the factors that are driving the North America market.
According to research report the global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%.
Growth in the structural heart devices market is mainly driven by factors such as the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favourable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753 Players in this market compete to deliver superior and advanced technologies for heart valve repair and replacement.
Edwards Lifesciences held the leading position in the global structural heart devices market in 2017 on account of its diverse portfolio of transcatheter and surgical heart valves.
The company pursues organic as well as inorganic growth strategies, such as product launches & approvals and acquisitions to further increase its market share and strengthen its foothold in the surgical heart devices market.
The unique beating-heart repair procedure for mitral valve patients of Harpoon Medical complements Edwards’ comprehensive portfolio of treatments for structural heart disease and reinforce its commitment to innovation in cardiac surgery.
